CME Outfitters to Host Interactive Medical Meeting on Benign Prostatic Hyperplasia May 17 in Conjunction with the American Urologic Association Annual Meeting

Clinical experts Kevin T. McVary, MD, FACS, Culley C. Carson, III, MD, FACS, Steven A. Kaplan, MD, and David R. Staskin, MD discuss how to optimize care for the management of benign prostatic hyperplasia using a brand new live interactive learning format in conjunction with AUA 2014.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

Bethesda, MD (PRWEB) April 10, 2014

CME Outfitters, LLC (CMEO) is hosting a brand new interactive CME symposium in conjunction with the 2014 American Urologic Association (AUA) conference in Orlando, Florida on May 17, 2014. In order to attend the symposium, clinicians must be registered for the AUA meeting. Registration is available at http://www.aua2014.org. Led by some of the nations most esteemed men’s health experts, the symposium entitled, Optimizing Care for the Management of Benign Prostatic Hyperplasia, will help clinicians establish guideline-based, measurement tools with all patients with BPH/LUTS to monitor symptoms, treatments response, and quality of life.

Truly unique to the general setting of medical symposia, the faculty will teach the course via an interactive case challenge workshop, where faculty will engage participants in collaborative discussion of the data using audience response technology, patient case vignettes, and mini-breakout sessions. Smaller breakout sessions allow for learners to have direct access to experts with a low faculty to attendee ratio, and is designed to identify challenges, share insights, and problem-solve to improve the care of patients with BPH and its comorbidities. For additional details about the session, please visit http://www.cmeoutfitters.com/CM879.

Faculty information, financial support, credit information, and disclosures are noted below.

FACULTY

Kevin T. McVary, MD, FACS (Moderator)
Professor and Chair
Division of Urology/Department of Surgery
Southern Illinois University School of Medicine
Springfield, IL

Culley C. Carson, III, MD, FACS
Rhodes Distinguished Professor of Urology
University of North Carolina
Chapel Hill, NC

Steven A. Kaplan, MD
E. Darracott Vaughan Jr. Professor of Urology
Chief, Institute for Bladder and Prostate Health
Weill Cornell Medical College
Director, Iris Cantor Men's Health Center
New York Presbyterian Hospital, Weill Cornell Medical Center
New York, NY

David R. Staskin, MD
Associate Professor of Urology
Tufts University School of Medicine
Steward Health-St. Elizabeth's Medical Center
Boston, MA

TARGET AUDIENCE
Urologists, nurses, nurse practitioners, physician assistants, and pharmacists caring for patients with benign prostatic hyperplasia.

FINANCIAL SUPPORT
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit http://www.lillygrantoffice.com.

CREDIT INFORMATION
CME Credit (Physicians):
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Outfitters designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
CNE Credit (Nurses): Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 2.0 contact hours

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 2.0 contact hours of pharmacotherapeutic contact hours.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 2.0 contact hours (0.20 CEUs) Universal Activity Number: 0376-0000-14-002-L01-P
Post-tests, credit request forms, and activity evaluations must be completed online at http://www.cmeoutfitters.com (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit http://www.neurosciencecme.com/technical.asp.

DISCLOSURE DECLARATION
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. McVary has disclosed that he has received research support from Allergan Inc.; Lilly and Company/ICOS Corporation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); and NeoTract, Inc. He is on the speakers bureau of GlaxoSmithKline. He serves as a consultant for Allergan Inc.; Lilly and Company/ICOS Corporation; NeoTract, Inc.; NxThera, Inc.; and Watson Pharmaceuticals, Inc.

Dr. Carson has disclosed that he has received grant and research support from Auxilium Pharmaceuticals, Inc. He serves on the speakers bureaus of American Medical Systems, Inc. (AMS); Auxilium Pharmaceuticals, Inc.; Eli Lilly and Company; and GlaxoSmithKline. Dr. Carson serves as a consultant for American Medical Systems, Inc. (AMS) and Auxilium Pharmaceuticals, Inc.

Dr. Kaplan has no disclosures to report.

Dr. Staskin has disclosed that he serves on the speakers bureau for Allergan Inc. and Astellas Pharma US, Inc. He is a consultant for Allergan, Inc.; AltheRX Pharmaceuticals; Astellas Pharma US, Inc.; and Endo-American Medical Systems, Inc. He received royalties from America Medical Systems, Inc.

John M. Rodgers, MD (peer reviewer) has no disclosures to report.

Robert Kennedy (planning committee) has no disclosures to report.

Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.

Sandra Haas Binford, MAEd (planning committee) has no disclosures to report.

UNLABELED USE DISCLOSURE
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC, the faculty, and Lilly do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use

About CME Outfitters, LLC
CME Outfitters (CMEO) is a leading accredited provider in continuing medical education. CMEO develops and distributes live, recorded and web-based, outcomes- and evidence-based educational activities to thousands of clinicians each year and offers expert accreditation and outcome services for non-accredited organizations. CME Outfitters focuses on delivering education to specialty audiences, with strong expertise in neuroscience, inflammatory, infectious, and autoimmune diseases, and cardiovascular disease. For a complete list of certified activities and more information, visit http://www.cmeoutfitters.com or call 877.CME.PROS (877.263.7767).

“CME Outfitters …
Improving Clinical Behavior … One Change at a Time”
###


Contact

  • Haley Hoffman
    CME OUtfitters LLC
    614-328-4529
    Email